Elevance Health stock gains 2.1 percent on September 22

Published on 09/23/2026 at 11:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Elevance Health stock closed at USD 347.84 on September 22, 2026, after a 2.1 percent rise. July revenue reached USD 49.83 billion.

Draufsicht-Arrangement mit Aktienzertifikat, ISIN-Karte US2855211023 und Stethoskop — Elevance Health US2855211023 Flatlay mit Aktienzertifikat ISIN-Karte Stethoskop und medizinischen Utensilien auf Marmor, Illustration mit AI erstellt.

Elevance Health stock (ISIN US2855211023) closed at USD 347.84 on the NYSE on September 22, 2026, up 2.1 percent from the prior close. The move came with trading volume of 2,100,000 shares, giving the latest session a clear market signal.

Quarterly revenue reaches USD 49.83 billion

In the quarter reported on July 15, 2026, Elevance Health posted earnings of USD 7.45 per share, above the consensus estimate of USD 6.21, according to MarketBeat on September 22, 2026. The USD 1.24 per-share difference is the article's clearest quantified comparison.

Revenue for that quarter was USD 49.83 billion, compared with a consensus estimate of USD 48.88 billion, while revenue increased 0.8 percent from the same quarter a year earlier, according to MarketBeat on September 22, 2026. The combination of a revenue beat and modest year-over-year growth places earnings execution ahead of the top-line expansion rate.

Guidance points to USD 26.75 EPS

For the first quarter of 2026, operating revenue totaled USD 49.5 billion, up 1.5 percent year over year, while adjusted diluted earnings per share reached USD 12.58, according to Fortune on September 22, 2026. The same report said Elevance raised its full-year 2026 adjusted diluted EPS guidance by USD 1.25 to at least USD 26.75.

That guidance gives the stock a second earnings anchor beyond the latest quarterly beat. The first-quarter benefit expense ratio was 86.8 percent, a cost metric that remains important because medical expenses directly affect the profitability of a health benefits provider.

Stock remains below its yearly high

The September 22 close of USD 347.84 remained below the reported 52-week high of USD 436.24 and above the 52-week low of USD 274.84, according to MarketBeat on September 22, 2026. The latest close was USD 88.40 below that high and USD 73.00 above the low.

MarketBeat also reported a consensus rating of Moderate Buy and an average price target of USD 440.90 on September 22, 2026. That target sits USD 93.06 above the latest close, while the company had a reported market capitalization of USD 87.62 billion.

Elevance Health stock closes at USD 347.84

Elevance Health stock closed at USD 347.84 on the NYSE on September 22, 2026. The dated market picture combines a 2.1 percent daily gain with quarterly EPS of USD 7.45, revenue of USD 49.83 billion and full-year 2026 adjusted EPS guidance of at least USD 26.75.